CTLA4 and cancer: CD4cyt are expanded in patients with heterozygous CTLA4 mutations, and the cytotoxicity of CD4+ T cells is increased in cancer patients after ICI therapy and in a mouse model of acute viral infection after CTLA4 blockade.